Please report any queries concerning the funding data grouped in the sections named "Externally Awarded" or "Internally Disbursed" (shown on the profile page) to
your Research Finance Administrator. Your can find your Research Finance Administrator at https://www.ucl.ac.uk/finance/research/rs-contacts.php by entering your department
Please report any queries concerning the student data shown on the profile page to:
Email: portico-services@ucl.ac.uk
Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
Email: portico-services@ucl.ac.uk
Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
Publication Detail
Prognosis of peripheral lung tumours related to size of the primary.
-
Publication Type:Journal article
-
Publication Sub Type:Journal Article
-
Authors:Treasure T, Belcher JR
-
Publication date:01/1981
-
Pagination:5, 8
-
Journal:Thorax
-
Volume:36
-
Issue:1
-
Status:Published
-
Country:England
-
Print ISSN:0040-6376
-
Language:eng
-
Keywords:Adenocarcinoma, Carcinoma, Squamous Cell, Female, Humans, Lung Neoplasms, Male, Prognosis
-
Author URL:
Abstract
Three hundred and fourteen cases of peripheral lung tumours managed surgically over a 15-year period have been analysed to re-examine the effect of tumour size on the probability of survival up to five years after operation. The cases were classified into four groups according to the size of the primary. There was a significant inverse relationship between tumour size and five-year survival over the four groups (p less than 0.05) but this relationship did not hold for the largest tumours. The tumours over 6 cm did no worse than the group one size smaller (4.5-6.0 cm). Analysis of the survival in each group revealed a different pattern of annual loss in the largest tumours which suggested that this group included carcinomas self-selected for less metastatic potential. The peripheral tumours as a whole included more undifferentiated but fewer small cell carcinomas than the overall chest clinic figures. Within the peripheral tumours squamous carcinomas became more common and adenocarcinomas less common with increasing size. No small cell or adenocarcinomas were found among the five-year survivors in the large tumour group. Because 20% of patients with tumours over 6 cm lived for five years in this group of 314 patients we do not believe that they should be excluded from operative treatment on the basis of size alone.
› More search options
UCL Researchers